| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Part of New Contract Manufacturing Agreement with SupraNaturals to Secure Additional Production Capacity
SupraNaturals is a leading private label manufacturer in the health and wellness industry
BUZZ BOMB™ pre-workout:
50mg caffeine for energy and focus.
Boosts performance potential.
Stick packs:
Convenient, no water needed.
Precise caffeine dose
Global Market Insights: Pre-Workout Supplements
Market Size in 2024: $19.6 billion
Projected Market Size by 2030: $27.9 billion
Compound Annual Growth Rate (CAGR): 5.9%
ESTERO, FL / ACCESS Newswire / September 16, 2025 / Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) ("Aspire" or the "Company"), developer of a multi-faceted patent-pending supplement delivery technology, announced today a strategic initiative to rapidly increase the production capacity of its BUZZ BOMB™ single dose caffeine pre-workout supplement through a new manufacturing relationship with SupraNaturals, a well-established contract manufacturer of nutritional and dietary supplements. As part of this agreement, Aspire Biopharma announced an initial production order of two million servings (100,000 20-packs) of BUZZ BOMB™ pre-workout supplement, marking a significant milestone in the Company's expansion efforts.
Aspire's BUZZ BOMB™ caffeine pre-workout supplement features 50mg of caffeine and is designed to support sustained energy and mental focus, helping athletes and fitness enthusiasts-or anyone needing a lift--maximize their performance potential. Aspire's stick packs are easy to use, do not need to be mixed with water, and contain a precise amount of caffeine.
Posted In: ASBP
